These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7559491)

  • 21. Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity.
    Liu XY; Pop LM; Schindler J; Vitetta ES
    MAbs; 2012; 4(1):57-68. PubMed ID: 22327430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a ricin fusion toxin targeted to the interleukin-2 receptor.
    Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham M
    Protein Eng; 1996 Oct; 9(10):913-9. PubMed ID: 8931131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
    Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
    Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotoxins containing A-chain of mistletoe lectin I are more active than immunotoxins with ricin A-chain.
    Tonevitsky AG; Agapov II; Shamshiev AT; Temyakov DE; Pohl P; Kirpichnikov MP
    FEBS Lett; 1996 Aug; 392(2):166-8. PubMed ID: 8772196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.
    FitzGerald DJ; Bjorn MJ; Ferris RJ; Winkelhake JL; Frankel AE; Hamilton TC; Ozols RF; Willingham MC; Pastan I
    Cancer Res; 1987 Mar; 47(5):1407-10. PubMed ID: 3493065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence.
    O'Hare M; Brown AN; Hussain K; Gebhardt A; Watson G; Roberts LM; Vitetta ES; Thorpe PE; Lord JM
    FEBS Lett; 1990 Oct; 273(1-2):200-4. PubMed ID: 2121540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells.
    Burbage C; Tagge EP; Harris B; Hall P; Fu T; Willingham MC; Frankel AE
    Leuk Res; 1997 Jul; 21(7):681-90. PubMed ID: 9301690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ricin A chain reaches the endoplasmic reticulum after endocytosis.
    Liu Q; Zhan J; Chen X; Zheng S
    Biochem Biophys Res Commun; 2006 May; 343(3):857-63. PubMed ID: 16564502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro model for toxin-mediated vascular leak syndrome: ricin toxin A chain increases the permeability of human endothelial cell monolayers.
    Lindstrom AL; Erlandsen SL; Kersey JH; Pennell CA
    Blood; 1997 Sep; 90(6):2323-34. PubMed ID: 9310483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
    Tonevitsky AG; Agapov II; Mechetner EB; Ershova GV; Toptygin AYu ; Sarma T; Shamshiev AT; Pfueller U
    Biochem Mol Biol Int; 1993 Dec; 31(6):1059-69. PubMed ID: 8193589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor.
    Frankel AE; Fu T; Burbage C; Chandler J; Willingham MC; Tagge EP
    Leukemia; 1997 Jan; 11(1):22-30. PubMed ID: 9001414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
    Newton DL; Nicholls PJ; Rybak SM; Youle RJ
    J Biol Chem; 1994 Oct; 269(43):26739-45. PubMed ID: 7929408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Vallera DA
    J Immunol; 1989 Mar; 142(5):1755-66. PubMed ID: 2465347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
    Embleton MJ; Charleston A; Robins RA; Pimm MV; Baldwin RW
    Br J Cancer; 1991 May; 63(5):670-4. PubMed ID: 2039690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-glycosylation does not affect the catalytic activity of ricin a chain but stimulates cytotoxicity by promoting its transport out of the endoplasmic reticulum.
    Yan Q; Li XP; Tumer NE
    Traffic; 2012 Nov; 13(11):1508-21. PubMed ID: 22882900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model.
    Chignola R; Pasti M; Candiani C; Franceschi A; Anselmi C; Tridente G; Colombatti M
    Int J Cancer; 1995 May; 61(4):535-41. PubMed ID: 7538979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action.
    Lidor YJ; O'Briant KC; Xu FJ; Hamilton TC; Ozols RF; Bast RC
    J Clin Invest; 1993 Nov; 92(5):2440-7. PubMed ID: 8227359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome.
    Soler-Rodríguez AM; Ghetie MA; Oppenheimer-Marks N; Uhr JW; Vitetta ES
    Exp Cell Res; 1993 Jun; 206(2):227-34. PubMed ID: 8388800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum.
    Jiao P; Zhang J; Dong Y; Wei D; Ren Y
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9585-9594. PubMed ID: 30141083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Directing ricin-based immunotoxins with targeting affibodies and KDEL signal peptide to cancer cells effectively induces apoptosis and tumor suppression.
    Park SG; Kim H; Jun H; Choi SY; Kim E; Kang S
    J Nanobiotechnology; 2022 Aug; 20(1):387. PubMed ID: 35999603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.